CGIAR AMR strategy by Wieland, Barbara
  
 
CGIAR Antimicrobial Resistance Hub 
A global research and development partnership for reducing agriculture-associated antimicrobial resistance 
 
CGIAR AMR Strategy 
This document summarizes CGIAR interests and plans in contributing to mitigating 
antimicrobial resistance (AMR) associated with agriculture, including livestock, aquaculture, 
and crop production, in low and middle-income countries, and its implications for public 
health globally. 
Introduction 
Antimicrobials are among the most important tools available to medical and veterinary 
professionals for curing disease and improving welfare, however, they are threatened by the 
emergence of AMR. The resulting lack of treatment options for infectious diseases in people 
and livestock jeopardizes human health as well as animal health, food and nutrition security, 
and livelihoods. The World Bank estimates that increasing drug resistance could reduce 
global livestock production by 7.5 per cent. The main driver of AMR emergence is the 
selection of resistant bacteria following use of antibacterial compounds. Misuse of 
antimicrobials is of growing concern and engenders negative consequences without health 
benefits. AMR of human-specific pathogens is largely due to medical use, however, 
agriculture has also been linked to AMR emergence. Depending on compounds used, 
humans, livestock, and fish excrete unmetabolized drugs, leading to contamination of the 
environment, including water systems, and adding to the complexity of AMR. This is a 
concern in intensifying livestock production and aquaculture systems that have direct 
linkages to water systems important for food production and water consumption. The 
complexities around AMR call for interdisciplinary solutions, bringing together social sciences 
and biosciences from public health, veterinary, and environmental sectors.  
Livestock 
In low and middle-income countries (LMICs), little is known about antimicrobial use in 
agriculture or how close interactions of livestock and people in smallholder production 
systems and emerging intensive production systems relate to AMR emergence. Counterfeit 
drugs, lack of regulations, and poor observance of withdrawal periods resulting in 
antimicrobial residues in animal-source foods pose challenges, coupled with limited 
incentives and lack of cost-effective, viable alternatives for reducing antimicrobial use. Poor 
knowledge amongst actors involved, from livestock keepers and producers to even some 
veterinary professionals and government officials, compounds the problem and highlights 
the need for capacity building at all levels. The lack of capacity is also apparent in surveillance 
systems, which require reliable and credible laboratories to detect new resistance patterns 
and process many samples to monitor AMR in livestock, livestock products, human 
populations, and to support monitoring and compliance systems to enforce regulations. 
Understanding livestock-associated AMR’s contribution to disease-resistant infections in 
humans requires novel, interdisciplinary collaboration between OneHealth (veterinary, 
environmental and public health) researchers, and the development of common tools and 
integrated research procedures.  
 
In many high-income countries, stringent regulations on antimicrobial use in livestock 
agriculture coupled with incentive systems have been put in place, and the careful 
monitoring of antibiotic consumption is increasing as a result. These countries demonstrate 
that with good husbandry and herd health practices, antibiotic use can be reduced without 
any undue effects on productivity. These experiences provide lessons that can be adapted by 
others, particularly in emerging middle-income countries.  
Aquaculture 
Aquaculture is an important and growing industry globally, with low and middle-income 
countries being well integrated in the global seafood trade. Projections suggest that by 2030, 
aquaculture production will double worldwide. Aquaculture systems are complex and 
dynamic, with many factors driving the (mis)use of antimicrobials. Use in aquaculture is 
different to that in humans and livestock species, since antimicrobials are administered 
directly into the aquatic environment, usually through medicated feed, increasing the 
potential for contamination and spread. Unlike terrestrial farming, in aquaculture, 
antimicrobials and feed are often supplied separately to farmers, in many parts of the world 
without involvement of an authorised veterinarian. Farmers then must mix the antimicrobials 
with the feed, resulting in a high potential risk of occupational exposure. Moreover, fish do 
not metabolize antimicrobials effectively, and it has been estimated that 75 per cent of 
antimicrobials fed to fish will be excreted back in their active form into the aquatic 
environment. 
 
In LMICs, antimicrobials are used extensively in aquaculture as “cure-all” and “increase 
productivity” strategies, to compensate for weaknesses in management and hygiene and lack 
of alternate fish health tools such as diagnostics and vaccines. Regulation for the responsible 
use of antimicrobials is often inefficient and surveillance or monitoring in many countries is 
lacking or absent. Efficient surveillance is in place in many production systems targeting 
export markets, but often absent in fish supply chains for domestic markets. Regulatory 
approaches with effective enforcement can lead to substantial reduction in antimicrobial use, 
as well as appropriate use of commercial vaccines for some fish species, as demonstrated in 
some high-income countries. As with livestock, high production and fish health standards 




Plant diseases place substantial constraints on agricultural production in LMICs. Antimicrobial 
use to control plant diseases is presently very limited, but may increase rapidly in response to 
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CGIAR’s past endeavours on AMR risk mitigation 
Antimicrobial resistance (AMR), which includes the resistance of bacterial, viral, parasitic and 
fungal microorganisms to drugs used to treat infections, has been recognized as one of the 
biggest challenges for humankind. While it is agreed that antibiotics use in people is the 
single biggest driver for AMR, use of antibiotics and other antimicrobials (acaricides and 
parasitic drugs) in agriculture and aquaculture cannot be neglected. If antimicrobials stop 
working, in the coming decades lives and livelihoods of millions of people are at risk, 
economic growth slowed, and global food security threatened. Accordingly, AMR jeopardizes 
the attainment of seven of the 17 sustainable development goals (SDGs), namely 1, 2, 3, 6, 8, 
12 and 17 (WHO, www.euro.who.int/sdgs). Pathogens with antimicrobial resistance genes 
and antimicrobial residues occur at the interface of people, animals and the environment, 
which highlights the need for interdisciplinary approaches, such as One Health, to mitigate 
AMR risks.  
Unlike in Europe and other developed regions, AM use is difficult to regulate in large parts in 
Asia and Africa. As livestock and aquaculture systems are intensifying in LMICs and access to 
drugs is becoming easier and increasingly unregulated, there is an urgent need for action. 
With its mandate to improve livelihoods of poor people through agriculture and food 
research, CGIAR is ideally positioned and has an obligation to tackle agriculture-associated 
AMR risks in low and middle-income countries by developing, testing and promoting 
sustainable solutions, bringing together technical, institutional and policy innovations. 
Accordingly, the CGIAR research portfolio’s focus on AMR has steadily grown in recent years 
in two CGIAR Research Programs (CRP Livestock, led by the International Livestock Research 
Institute (ILRI) and Agriculture for Nutrition and Health (A4NH), led by the International Food 
Policy Research Institute (IFPRI)) and links to the CRP on Fish, led by World Fish and potential 
links to the CRP on Water Land and Ecosystems led by the International Water Management 
Institute (IWMI). This portfolio of projects includes grants focusing on antimicrobial use and 
on AMR emergence in risk hot spots characterized through close interactions of people, 
animals, and environment (One Health) and has resulted in strong partnerships with 
academic partners, among others the University of Liverpool, the Swedish University for 
Agricultural Sciences, the University of Exeter (UK) and the UK AMR Centre of Excellence. 
Significantly, through the involvement of the London School of Hygiene and Tropical 
Medicine as a managing partner in A4NH, public health research partnerships have been 
strengthened, creating capacity to design and evaluate interventions that demonstrably 
reduce the risk of disease-resistant infections in humans arising from agriculture. Additional 
partnerships, including with the new International Centre AMR Solutions (ICARS) in Denmark 
are being developed.  
CRP Livestock and A4NH contribute to research on the complex pathways of AMR. Both 
programs start with the use of antimicrobials in livestock and fish production, with CRP 
Livestock focusing on the livestock health impacts and A4NH on the implications for human 
health.   
 
CRP Livestock concentrates on antimicrobial use and productivity since AMR will lead to 
treatment failure in livestock. It aims to promote rational and efficient use of antimicrobials 
and, more explicitly, how rational use can be promoted when integrated into herd health 
packages. This will be achieved through building capacity, testing alternatives to 
antimicrobials, and creating incentives to refine their use. Outputs of the different studies 
provide evidence and convincing arguments to engage policymakers in the AMR discussion, 
and CRP Livestock aims to support countries in setting up appropriate antibiotic use 
strategies for livestock. 
A4NH focuses on understanding the drivers of AMR emergence in livestock and fish systems 
and their implications for human health. To better understand human AMR risks due to 
antimicrobial use in agriculture, studies into the biology, ecology, and epidemiology of 
microbes across livestock and fish production, environment, and public health contexts are 
conducted in specific sites. Whole genome sequencing helps identifying movement of AMR 
genes between these areas and drivers of AMR emergence and transmission. To test how 
these drivers can be mitigated, intervention studies will be conducted in hotspot sites. 
Evidence from these studies will then be used to support informed policy decisions in 
relevant sectors.  
 
CGIAR AMR strategy 
To tackle AMR challenges in low and middle-income countries and ensure the sustainability 
of global food and health systems, the CGIAR AMR strategy is organised around a CGIAR AMR 
hub to facilitate interactions between CGIAR partners and other international and national 
partners. This approach allows fostering learning from past experiences, support AMR 
research excellence in the global south, and ensure a critical mass of research to find suitable 
and sustainable solutions. The CGIAR AMR hub is hosted and led by ILRI with ILRI being 
responsible, through its co-leadership of A4NH One Health and AMR research, for bringing in 
other important CGIAR and partner capacity. LSHTM, as co-lead with ILRI in this work under 
A4NH, provides an on-going and credible public health partnership that can be built upon 
through the AMR hub. Also, importantly, ILRI will work closely with IFPRI, A4NH’s lead center, 
to leverage IFPRI’s in-country policy support activities to link AMR policy and regulation 
discussions into the broader food and development policy arena in multiple low and middle-
income countries and globally.  
 
The CGIAR AMR strategy builds on five pillars of research and interventions: 
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1. AM use and value chains: Understand knowledge, attitude, practices, and incentives 
for antimicrobial use or reduction in use and role of formal and informal markets. This 
includes distribution networks, types of products used, and the way in which new 
antimicrobials, particularly those classified by WHO as Critical Important Antibiotics 
(CIA), are used; 
2. Transmission dynamics: Research AMR transmission dynamics at the human-animal-
environmental interface in different agricultural systems using systems approaches; 
Understand the role of residues in agricultural products  
3. Design and evaluate interventions to reduce and more effectively use antimicrobials 
in agriculture in low and middle-income countries focussing on public health 
outcomes.   
4. Support evidence-based policy dialogue for antimicrobial surveillance and AMR 
strategies;  
5. Capacity development and scaling of interventions.  
 
Geographical reach: the CGIAR AMR strategy aims to support the efforts of low and middle-
income countries globally, drawing on the lessons from high-income countries. The current 
research partnership around ILRI has a strong presence in Africa and Asia, with links in South 
America under development. Below is an overview of proposed activities under each of the 
five pillars to be coordinated through the AMR-Hub: 
1. Understand knowledge, attitude, practices, and incentives for antimicrobial use in 
low- and middle-income countries and role of formal and informal markets: 
Partnerships







• Collect and collate  data on use of antimicrobials in livestock, aquaculture, and crops 
(antibiotic classes, dosage); 
• Understand stakeholder behaviour for antimicrobial use; 
• Assess quality and governance of antimicrobials used in humans, livestock, fish, and 
crops;  
• Understand incentives and rationales for antimicrobial use in agricultural systems; 
and 
• Conduct research on formal and informal antimicrobial markets and access of 
producers to these markets. 
 
2. Research AMR transmission dynamics at the human-animal-environmental interface 
in different agricultural systems and role of residues:  
• Collect data on the extent of antimicrobial-resistant bacteria found in livestock, fish, 
humans, the environment, and food;  
• Conduct research to understand the transmission and genetic mechanisms of 
resistance in agriculture and the implications for human and animal health; and  
• Develop a range of mathematical and biological models of AMR in low- and middle-
income countries to understand the relative contribution of agricuturally-associated 
AMR to the human AMR burden and risk of drug resistant infections in different 
contexts.  
 
3. Design and evaluate interventions to reduce antimicrobial use in agriculture in low- 
and middle-income countries:  
• Develop and evaluate the impact of a range of local interventions in agricultural 
systems to reduce AMR risks to human populations, taking a transdisciplinary 
approach which engages researchers and stakeholders from different sectors; 
• Develop and test gender-sensitive pest and pathogen controls to better manage 
livestock and fish diseases and reduce the use of antimicrobials; 
• Explore feasibility of incentive-based systems, especially intensifying production 
systems; 
• Understand the costs and benefits of interventions to tackle AMR, at different levels 
of analysis (stakeholder, value chain, national); 
• Characterise gender-differential impacts of interventions on poor farmers, vulnerable 
groups and address other societal objectives such at attaining nutrition security; and  
• Understand the potential of market demand/pull for responsibly-produced foods 
(animal source foods, fish, and crops).  
 
4. Support evidence-based policy dialogue for antimicrobial surveillance and AMR 
strategies: 
• Synthesize evidence on antimicrobial use and AMR to influence public policy and the 
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• Generate evidence to promote good practices in the governance, supply, use, and 
disposal of agriculture-associated antimicrobials and identify incentives that facilitate 
their adoption; 
• Engage policymakers in agriculture and health, and encourage integrated policy 
approaches supported by experimental evidence, in the context of OneHealth 
solutions;  
• Pilot and evaluate approaches for surveillance of use of antimicrobials, treatment 
failure, and AMR; and 
• Contribute to mapping existing and projecting future use of antimicrobials in the face 
of increasing intensification.  
 
5. Capacity development and scaling: 
• Support capacity building and increase awareness of AMR in the agricultural sector 
(veterinarians, livestock and fish producers, and service providers); 
• Support exchange programs for LMIC researchers with the AMR Centre of Excellence 
in Denmark and other affiliated institutions; 
• Provide and facilitate access to research facilities for researchers from low and 
middle-income countries 
• Organize and run training programs on AMR, including research and mitigation, using 
modern online and interactive formats as appropriate to the intended audience 
• Facilitate scaling of promising interventions/solutions 
 
 
ILRI as host of the CGIAR AMR Hub  
 
ILRI leads the AMR components of both CRP Livestock and A4NH. Through ongoing research, 
ILRI has established strong partnerships with other key players in AMR research, including the 
Swedish Agricultural University (SLU), London School of Hygiene and Tropical Medicine 
(LSHTM), University of Liverpool and the Royal Veterinary College, and works on international 
One Health and livestock sector platforms with World Health Organization (WHO), World 
Organization for Animal Health (OIE),  Food and Agriculture Organization of the United 
Nations (FAO), and the African Union. Significantly, through LSHTM’s role as a managing 
partner in A4NH, public health research partnerships have been strengthened, creating 
capacity to design and evaluate interventions that demonstrably reduce the risk of disease-
resistant infections in humans arising from agriculture.  
 
Being a CGIAR center, ILRI has close links to other centers and CRPs beyond Livestock and 
A4NH. ILRI has its headquarters in Nairobi, Kenya, a principal campus in Addis Ababa, 
Ethiopia, and 14 country offices throughout Africa and Asia with ongoing research projects in 
many more countries. ILRI hosts six other CGIAR centers in Nairobi and 11 in Addis Ababa. As 
with other CGIAR centers, over the years, ILRI has established close collaborations with 
national agricultural research systems and, more recently, with public health research 
 
institutions through A4NH. This provides a very strong network of national partners on the 
ground.  
 
In addition to these relationships, ILRI also hosts, on behalf of the African Union/NEPAD, the 
Bioscience east and central Africa-ILRI (BecA-ILRI) Hub, a shared agricultural research and 
biosciences platform to increase access to affordable, world-class research facilities. The 
BecA-ILRI Hub provides a shared biosciences research platform, research-related services, 
and capacity building opportunities to eastern and central Africa and beyond. 
 
Purpose and benefits of the CGIAR AMR-Hub 
The key function of the CGIAR AMR hub will be to oversee the implementation of the CGIAR 
AMR strategy and to convene different stakeholders with interest in AMR research, and 
provide an enabling environment for research partnerships and through that foster existing 
and facilitate the establishment of new research partnerships.  
The hub thus will: 
• Provide a state-of-the-art technical platform to share and improve all necessary 
microbiological analysis, various AMR tests and residue testing, as well as all relevant 
assessments of policies, incentives, regulations, and practices that effectively reduce 
excessive use of antimicrobials 
• Strengthen partnerships within and outside the CGIAR, particularly with national 
research and development partners in Africa and Asia and the public health sector 
• Host and maintain an online agri-food system AMR information platform 
• Host a long-term biobank 
• Run a data storage platform for AMR related CGIAR projects 
• Organise regular trainings on different aspects of AMR for CGIAR and national partner 
institutions involved in AMR work 
• Convene stakeholders on AMR to discuss solutions and provide support for AMR 
advocacy and policy making and to agree on CGIAR positioning on AMR research 
• Ensure CGIAR-AMR research is aligned through ongoing coordination between CGIAR 
partners involved. 
• Provide a cross-CGIAR institutional set-up for coordinated AMR research and 
development activities (for example serve to facilitate partnership with new partners 
such as the International AMR Centre in Denmark and provide space to host visiting 
scientists).  
• Generate knowledge and capabilities among national governments and partners to 
comply with OIE, World Trade Organization (WTO) and Codex trade requirements 
 
The expected benefits of the CGIAR AMR-hub thus are: 
- Urgently needed evidence on ways to mitigate agri-food system associated AMR risks 
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CGIAR partner centers Supported by 
- Strengthened advocacy and communication on agri-food system associated AMR 
- Compelling evidence and support for donors on critical AMR research gaps in LMICs 
- A growing, well-managed AMR research portfolio across the CGIAR facilitating 
collaboration between centres and CRPs 
- Better access for national science partners to international AMR research community 
- New significant partnerships around AMR 
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